A new CDC guideline for prescribing opioids for pain recently became available.1 Nonopioid drugs for pain were reviewed in a previous issue.2
ACUTE PAIN — For many types of moderate to severe acute pain, acetaminophen and/or an NSAID may be as effective as an opioid.3,4 Use of caffeine as a co-analgesic may provide some additional pain relief.5 If nonopioid drugs and nonpharmacologic treatment (e.g., heat or...
- Antiviral Drugs for Influenza for 2022-2023
- Relyvrio for ALS
- In Brief: Alternatives to Adderall
- Comparison Chart: Antiviral Drugs for Influenza for 2022-2023 (online only)
- COVID-19 Update: Resistance to Bebtelovimab (online only)
- Maribavir (Livtencity) for Cytomegalovirus Infection (online only)
- Margetuximab (Margenza) for HER2-Positive Breast Cancer (online only)
- Mobocertinib (Exkivity) for Non-Small Cell Lung Cancer (online only)
RELEASE
The FDA has approved a sublingual film formulation of the alpha-2 adrenergic receptor agonist dexmedetomidine (Igalmi — BioXcel Therapeutics) for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It is the first alpha-2 agonist and the only sublingual film to be approved for this indication. Dexmedetomidine has been available for many years in an injectable formulation (Precedex) for sedation in the intensive care …